Ascendis Pharma A/S Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions EUR

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Ascendis Pharma A/S (ASND) - Annual data in billions EUR
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Jan 2023Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents0.560.400.440.450.58
Short-Term Investments0.000.010.290.240.13
Cash & Short-Term Investments0.560.400.740.680.72
Accounts Receivable0.170.060.030.000.01
Inventory0.300.210.130.080.00
Other Current Assets0.040.040.030.030.01
Total Current Assets1.060.700.920.810.74
Non-Current Assets
Property, Plant & Equipment (Net)0.100.110.130.130.11
Long-Term Investments0.010.010.030.040.12
Goodwill0.000.000.000.000.00
Intangible Assets0.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.120.120.170.280.24
Total Assets1.180.831.091.080.98
Current Liabilities
Accounts Payable0.100.100.100.060.02
Short-Term Debt0.490.410.400.010.00
Current Portion of Long-Term Debt0.480.410.400.000.00
Accrued Liabilities0.070.040.030.030.02
Deferred Revenue0.000.000.000.000.00
Other Current Liabilities0.320.040.170.030.02
Total Current Liabilities0.910.200.720.100.05
Non-Current Liabilities
Long-Term Debt0.370.620.100.100.09
Deferred Tax Liabilities0.010.010.000.000.00
Other Non-Current Liabilities0.000.000.040.120.00
Total Non-Current Liabilities0.380.770.110.100.09
Total Liabilities1.290.970.830.200.14
Stockholders' Equity
Common Stock0.010.010.010.010.01
Retained Earnings-2.56-2.28-1.86-1.24-1.03
Accumulated Other Comprehensive Income0.000.000.000.880.13
Treasury Stock0.000.000.000.000.00
Shares Outstanding0.060.060.060.060.00
Total Stockholders' Equity-0.11-0.150.260.880.84
Total Liabilities & Equity1.180.831.091.080.98